News
July 27, 2022

LOINC® from Regenstrief returns to in-person learning with conference in Annecy, France

LOINC Conference photo

On-site attendance encouraged for most valuable experience

LOINC® from Regenstrief Institute, a global healthcare terminology standard, is returning to in-person learning at its semi-annual conference October 24-27, 2022, in Annecy, France.

Registration for the conference gains access to presentations. Content will include:

  • a framework for newer users and to bolster knowledge for advanced users;
  • sessions led by LOINC community members who are applying and administering LOINC codes in the field;
  • committee meetings to discuss healthcare trends and the impact on LOINC and other data standards; and
  • access to conference resources after the event.

To view the preliminary schedule, register for the conference and access a sampling of past workshops and presentations from LOINC’s most recent, online-only conference in March 2021, visit the LOINC conference website.

“We are very excited to announce the return of our in-person conference,” said Marjorie Rallins, DPM, M.S., executive director of LOINC and Health Data Standards from Regenstrief. “The event will be held at Les Pensières Center for Global Health in Annecy, France. We encourage anyone who can to attend in person to reap the greatest benefit that comes with live collaboration, conversation and interaction. However, we will be offering a virtual option. While we are committed to hosting this as a face-to-face event, we will continue to monitor the global health situation and make any adjustments necessary to ensure the health and safety of our LOINC team and community.”

LOINC conference attendees are engaged learners from around the globe and will represent a variety of industries such as software, device manufacturers, healthcare providers, laboratories, government agencies, and research and educational institutions. As with prior conferences, attendees can expect opportunities for hands-on learning, expert discussions and engaging presentations from a wide range of authorities and specialists in health data and informatics.

LOINC, which stands for Logical Observation Identifiers Names and Codes, is a standard for identifying health measurements, observations, and documents. Created and maintained at Regenstrief Institute, LOINC enables the identification, exchange and collection of data across health systems and is used around the world. The current COVID-19 pandemic has highlighted and further emphasizes the value of this standard and its impact on data interoperability.

About LOINC® from Regenstrief
LOINC® was created in 1994 at Regenstrief Institute to facilitate interoperability in healthcare. There was a growing trend to send clinical data electronically between healthcare entities, a practice that has now become ubiquitous. Today, it contains more than 100,000 terms for everything from a serum alpha 1 antitrypsin level to a zygomatic arch x-ray report. For each concept, LOINC contains many other rich details, such as synonyms, units of measure, and carefully crafted descriptions.

About Regenstrief Institute
Founded in 1969 in Indianapolis, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its research scientists are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform practice and improve the lives of patients around the globe.

Sam Regenstrief, a nationally successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute’s research mission.

 

Related News

image of pregnant woman with vaccine acting as protection from COVID virus

National CDC-funded study confirms that mRNA vaccines protect against serious COVID-19 during pregnancy

The first large, real-world study of the effectiveness of mRNA COVID-19 vaccines during pregnancy found these vaccines, especially two

Thomas Imperiale

Journal editorial: Regenstrief researcher calls for tailoring colorectal cancer screening for 45-to-49-year-olds

It’s been a year since national recommendations issued by the American Cancer Society and the U.S. Multi-Society Task Force

Dr. Shaun Grannis on data surveillance of post-COVID conditions

Dr. Shaun Grannis on data surveillance of post-COVID conditions

Regenstrief Vice President for Data and Analytics Shaun Grannis, M.D., M.S., discusses the questions that will be investigated in

Screening tools co-developed by Regenstrief Institute research scientist help clinicians assess and treat vexing symptoms

Screening tools co-developed by Regenstrief Institute research scientist help clinicians assess and treat vexing symptoms

Widely used scales measure pain, depression, anxiety, suicide risk, cancer fatigue and now symptoms associated with a common dental